AMCP to Supreme Court: Ruling Against PCMA Could Raise Health Costs
April 3, 2020
The Academy of Managed Care Pharmacy (AMCP) in an amicus brief filed in the Supreme Court tells the court ruling against the Pharmaceutical Care Management Association (PCMA) in Rutledge v. PCMA could have a negative impact on costs and patient outcomes.
According to a press release, the case revolves around an Arkansas law which aims to regulate how PBMs contract with pharmacies.
“The proliferation of 50 varying state regulations would further fracture our health care system, making it challenging if not impossible for managed care professionals to efficiently apply proven tools and practices, such as formulary management, that provide millions of patients the best possible benefits for their prescribed medications at the lowest possible costs,” said AMCP CEO Susan Cantrell.
To read the full press release, click here.
